These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8301935)

  • 1. Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells.
    Krämer A; Nauck M; Pavenstädt H; Schwedler S; Wieland H; Schollmeyer P; Wanner C
    Kidney Int; 1993 Dec; 44(6):1341-51. PubMed ID: 8301935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential uptake of intermediate-density lipoproteins from nephrotic patients by human mesangial and liver cells.
    Krämer-Guth A; Nauck M; Pavenstädt H; Königer M; Wieland H; Schollmeyer P; Wanner C
    J Am Soc Nephrol; 1994 Oct; 5(4):1081-90. PubMed ID: 7849247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells.
    Krämer-Guth A; Quaschning T; Pavenstädt H; Galle J; Nauck M; Baumstark MW; Schollmeyer P; März W; Wanner C
    Nephrol Dial Transplant; 1997 Jul; 12(7):1336-43. PubMed ID: 9249767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells.
    Gröne HJ; Walli AK; Gröne E; Krämer A; Clemens MR; Seidel D
    Kidney Int; 1990 Jun; 37(6):1449-59. PubMed ID: 2163465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells.
    Quaschning T; Königer M; Krämer-Guth A; Greiber S; Pavenstädt H; Nauck M; Schollmeyer P; Wanner C
    Nephrol Dial Transplant; 1997 Dec; 12(12):2528-36. PubMed ID: 9430847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
    Vaziri ND
    Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria.
    Warwick GL; Packard CJ; Demant T; Bedford DK; Boulton-Jones JM; Shepherd J
    Kidney Int; 1991 Jul; 40(1):129-38. PubMed ID: 1921148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VLDL and LDL metabolism in human and rat mesangial cells.
    Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Wieland H; Schollmeyer P; Wanner C
    Nephron; 1996; 74(2):378-85. PubMed ID: 8893159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular metabolism of human plasma intermediate-density lipoprotein (IDL).
    Friedman G; Gavish D; Vogel T; Eisenberg S
    Biochim Biophys Acta; 1990 May; 1044(1):118-26. PubMed ID: 2340301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial lipoprotein lipase deficiency: abnormal lipoproteins and defective metabolism of low density lipoproteins in cultured human skin fibroblasts.
    Kleinmann Y; Oschry Y; Berger GM; Eisenberg S
    Atherosclerosis; 1988 Jun; 71(2-3):197-204. PubMed ID: 3401291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
    Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix.
    Krämer-Guth A; Greiber S; Pavenstädt H; Quaschning T; Winkler K; Schollmeyer P; Wanner C
    Kidney Int; 1996 May; 49(5):1250-61. PubMed ID: 8731088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal high density lipoproteins from patients with liver disease regulate cholesterol metabolism in cultured human skin fibroblasts.
    Owen JS; Goodall H; Mistry P; Harry DS; Day RC; McIntyre N
    J Lipid Res; 1984 Sep; 25(9):919-31. PubMed ID: 6491539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
    Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
    Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.